Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-23T06:58:22.176Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Presentation and Course of SARS-CoV-2 Infection in Health-Care Personnel Working in Dedicated COVID-19 Hospital During 2 Pandemic Waves in India

Published online by Cambridge University Press:  20 December 2021

Ashish Bindra ,
Neha Sharma ,
Sheeba Joseph ,
Purva Mathur ,
Rajesh Malhotra  and
Maroof A. Khan
Ashish Bindra*
Affiliation:
Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India
Neha Sharma
Affiliation:
Neuroanaesthesiology and Critical Care, Jai Prakash Narayan Apex Trauma Centre (JPNATC), All India Institute of Medical Sciences, New Delhi, India
Sheeba Joseph
Affiliation:
Jai Prakash Narayan Apex Trauma Centre (JPNATC), All India Institute of Medical Sciences, New Delhi, India
Purva Mathur
Affiliation:
Lab Medicine, Jai Prakash Narayan Apex Trauma Centre (JPNATC), All India Institute of Medical Sciences, New Delhi, India
Rajesh Malhotra
Affiliation:
Jai Prakash Narayan Apex Trauma Centre (JPNATC) All India Institute of Medical Sciences, New Delhi, India
Maroof A. Khan
Affiliation:
Biostatistics, All India Institute of Medical Sciences, New Delhi, India
*
Corresponding author: Ashish Bindra, Email: dr_ashi2208@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Health-care personnel (HCPs) are predisposed to infection during direct or indirect patient care as well as due to the community spread of the disease.

Methods:

We observed the clinical presentation and course of severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) infection in HCPs working in a dedicated coronavirus disease 2019 (COVID-19) care hospital during the first and the second wave.

Results:

A total of 100 and 223 HCPs were enrolled for the first wave and the second wave, respectively. Cough, shortness of breath, sore throat, runny nose, and headache was seen in 40 (40%) and 152 (68%) (P < 0.01), 15 (15%) and 64 (29%) (P = 0.006), 40 (40%) and 119 (53.3%) (P = 0.03), 9 (9%) and 66 (30%) (P < 0.01), 20 (20%) and 125 (56%) (P < 0.01), respectively. Persistent symptoms at the time of joining back to work were seen in 31 (31%) HCPs and 152 (68%) HCPs, respectively (P ≤ 0.01). Reinfection was reported in 10 HCPs.

Conclusions:

Most of the HCPs had mild to moderate infections. Symptoms persist after joining back to work. Upgradation of home-based care and teleconsultation facilities for active disease and redressal of residual symptoms will be helpful.

Keywords

clinical symptomshealth-care personnelSARS-CoV-2persistent symptoms
Type
Original Research
Information
Disaster Medicine and Public Health Preparedness , Volume 17 , 2023 , e90
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

CDC COVID-19 Response Team. Characteristics of health care personnel with COVID-19 - United States, February 12-April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:477-481.CrossRefGoogle Scholar
Jain, VK, Iyengar, KP, Vaishya, R. Differences between the first wave and second wave of COVID-19 in India. Diabetes Metab Syndr. 2021;15:1047-1048. DOI: 10.1016/j.dsx.2021.05.009 CrossRefGoogle ScholarPubMed
Kumar, P, Killedar, M, Singh, G. Adaptation of the ‘assembly line’ and ‘brick system’ techniques for hospital resource management of personal protective equipment, as preparedness for mitigating the impact of the COVID-19 pandemic in a large public hospital in India. J Hosp Infect. 2020;105:787-789. DOI: 10.1016/j.jhin.2020.05.029 CrossRefGoogle Scholar
Sharma, N, Gupta, A, Killedar, M, et al. One for everyone: a study of user satisfaction among health-care providers regarding extended Use of N95 masks during the COVID-19 pandemic. Disaster Med Public Health Prep. 2020;12:1-8. DOI: 10.1017/dmp.2020.380 Google Scholar
Soriano, V, Ganado-Pinilla, P, Sanchez-Santos, M, et al. Main differences between the first and second waves of COVID-19 in Madrid, Spain. Int J Infect Dis. 2021;105:374-376. DOI: 10.1016/j.ijid.2021.02.115 CrossRefGoogle ScholarPubMed
Carfì, A, Bernabei, R, Landi, F, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603-605.CrossRefGoogle ScholarPubMed
Townsend, L, Dyer, AH, Jones, K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of the severity of initial infection. PLoS One. 2020;15:e0240784.Google ScholarPubMed
Folgueira, MD, Munoz-Ruiperez, C, Alonso-Lopez, MA, et al. SARS-CoV-2 infection in health care personnel in a large public hospital in Madrid, Spain, during March 2020. medRxiv. 2020. DOI: 10.1101/2020.04.07.20055723 CrossRefGoogle Scholar
Rajasingham, R, Bangdiwala, AS, Nicol, MR, et al. Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial. Clin Infect Dis. 2021;72(11):e835-e843.CrossRefGoogle ScholarPubMed
Iwasaki, A. What reinfections mean for COVID-19. Lancet Infect Dis. 2021;21:3-5. DOI: 10.1016/S1473-3099(20)30783-0 CrossRefGoogle ScholarPubMed
Vitale, J, Mumoli, N, Clerici, P, et al. Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy. JAMA Intern Med. 2021;181(10):1407-1408. DOI: 10.1001/jamainternmed.2021.2959 CrossRefGoogle Scholar
Thiagarajan, K. Covid-19: India is at centre of global vaccine manufacturing, but opacity threatens public trust. BMJ. 2021;372:n196.Google ScholarPubMed
MacDonald, NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161-4164.CrossRefGoogle ScholarPubMed
Lin, Y, Hu, Z, Zhao, Q, et al. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14:e0008961. DOI: 10.1371/journal.pntd.0008961 CrossRefGoogle ScholarPubMed